New York 2025-2026 Regular Session

New York Assembly Bill A04100

Introduced
1/31/25  
Refer
1/31/25  

Caption

Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

Summary

Bill A04100 establishes an emergency insulin program in New York to ensure that individuals diagnosed with type one or insulin-dependent type two diabetes can access emergency supplies of analog insulins and related supplies. The program will be administered by the commissioner of health, who is tasked with engaging manufacturers to facilitate quick access to affordable insulin in emergency situations. The bill outlines the definitions of key terms, eligibility criteria for recipients, and the roles of healthcare professionals and pharmacists in prescribing and dispensing insulin under this program.

Impact

The bill will amend the public health law and state finance law, creating a new framework for emergency access to insulin. It establishes an emergency insulin program trust fund, which will be funded by appropriations and contributions from insulin manufacturers. This program aims to alleviate the burden on uninsured or underinsured individuals who are at risk of serious health consequences due to a lack of access to necessary insulin supplies, thereby potentially reducing emergency health incidents related to diabetes management.

Sentiment

The sentiment surrounding Bill A04100 appears to be generally supportive, as it addresses a critical health need for individuals with diabetes. However, there may be concerns regarding the implementation of the program, including the logistics of engaging manufacturers and ensuring sufficient funding for the trust fund. The absence of voting history and committee discussions makes it difficult to gauge the full extent of support or opposition from lawmakers.

Contention

Notable points of contention may arise regarding the funding mechanisms for the emergency insulin program trust fund and the responsibilities placed on manufacturers and healthcare providers. Some stakeholders may express concerns about the sustainability of the program and whether it adequately addresses the needs of all potential recipients, particularly those who are uninsured or underinsured. The balance between public health needs and private sector involvement could also be a topic of debate.

Companion Bills

NY S01917

Same As Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

Previously Filed As

NY S01917

Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

NY S03222

Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

NY SB5326

Accessing an emergency supply of insulin.

NY H1212

Relative to emergency insulin access

NY H4944

Relative to emergency insulin access

NY S2812

Requires DOH to maintain emergency stockpile of insulin and authorizes dispensing of emergency supply of insulin to certain patients.

NY A4324

Requires DOH to maintain emergency stockpile of insulin and authorizes dispensing of emergency supply of insulin to certain patients.

NY HB1380

Oklahoma Health Care Authority; Insulin Access and Affordability Program; effective date; emergency.

NY HB1380

Oklahoma Health Care Authority; Insulin Access and Affordability Program; effective date; emergency.

NY SB926

State Medicaid program; requiring coverage of insulin and insulin delivery systems; specifying certain covered system. Effective date. Emergency.

Similar Bills

No similar bills found.